Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Alzheimer Disorders

Volume 8

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2451-8743 (Print)
ISSN: 2214-5168 (Online)
ISBN: 978-981-14-0190-9 (Print)
ISBN: 978-981-14-0189-3 (Online)
Year of Publication: 2019
DOI: 10.2174/97898114018931190801

Introduction

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in the field of Alzheimer’s disease research.

The eighth volume of this series features chapters covering critical discussions on new therapies for AD. The reviews in this volume include:

  • -Novel Molecular Targets of Tauopathy; Therapeutic and Diagnostic Applications
  • -The Therapy of Alzheimer’s Disease: Towards a New Generation of Drugs
  • -Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease?
  • -Use of Antipsychotics in Patients with Alzheimer’s Disease
  • -Approaches Based on Cholinergic Hypothesis and Cholinesterase Inhibitors in the Treatment of Alzheimer's Disease
  • -Potential Biological Mechanisms with Prophylactic Action in Rapid Cognitive Impairment in Late-Onset Alzheimer's Disease

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College, University of Cambridge
Honorary Life Fellow
Cambridge
UK




Contributor(s):
Azime-Berna ÖZÇELİK
Department of Pharmaceutical Chemistry
Gazi University, Faculty of Pharmacy
Ankara
Turkey


Cristina Pintado-Losa
Biochemistry Area
Faculty of Environmental Sciences and Biochemistry, University of Castilla-La Mancha
Toledo
Spain


Dragoș Marinescu
Member of the Romanian Academy of Medical Sciences, University of Medicine and Pharmacy of Craiova, Doctoral School
Interim President of the Romanian Society for Biological Psychiatry and Psychopharmacology
Romania


Emma Burgos-Ramos
Biochemistry Area
Faculty of Environmental Sciences and Biochemistry, University of Castilla-La Mancha
Toledo
Spain


Fulvio Loiodice
Dipartimento di Farmacia–Scienze del Farmaco
Università degli Studi di Bari “Aldo Moro”
Via E. Orabona 4, 70125 Bari
Italy


Haiyun Xu
The Mental Health Center, Shantou University Medical College, Shantou
PR China


Ileana Marinescu
Department of Psychiatry
University of Medicine and Pharmacy of Craiova
Craiova
Romania


Jue He
First Affiliated Hospital, Institute of Neurological Disease, Henan University
Henan
PR China;
/
Xiamen Xian Yue Hospital
Xiamen
Fujian
PR China


Laurențiu Mogoantă
Department of Morphopathology
University of Medicine and Pharmacy of Craiova
Craiova
Romania


Luca Piemontese
Dipartimento di Farmacia–Scienze del Farmaco
Università degli Studi di Bari “Aldo Moro”
Via E. Orabona 4, 70125 Bari
Italy


Maria Amélia Santos
Centro de Química Estrutural
Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1
1049-001 Lisboa
Portugal


María Rodríguez-Pérez
Biochemistry Area
Faculty of Environmental Sciences and Biochemistry, University of Castilla-La Mancha
Toledo
Spain


Mehtap UYSAL
Department of Pharmaceutical Chemistry
Gazi University, Faculty of Pharmacy
Ankara
Turkey


Mohamed El-Gamal
Toxicology Department & Medical Experimental Research Center (MERC)
Faculty of Medicine, Mansoura University
Mansoura
Egypt;
/
IUF – Leibniz Research Institute for Environmental Medicine
Düsseldorf
Germany


Mohamed Salama
Toxicology Department & Medical Experimental Research Center (MERC)
Faculty of Medicine, Mansoura University
Mansoura
Egypt


Oscar Gómez-Torres
Biochemistry Area
Faculty of Environmental Sciences and Biochemistry, University of Castilla-La Mancha
Toledo
Spain


Puiu Olivian Stovicek
Department of Pharmacology
“Titu Maiorescu” University of Bucharest, Faculty of Nursing, Târgu Jiu
Romania



Sílvia Chaves
Centro de Química Estrutural
Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1
1049-001 Lisboa
Portugal


Xiaoyin Zhuang
The Mental Health Center, Shantou University Medical College, Shantou
PR China


Yasmeen M. Taalab
Toxicology Department
Faculty of Medicine, Mansoura University
Mansoura
Mansoura;
/
German Institute of Disaster Medicine and Emergency Medicine
Tubingen
Germany


Yuan Shao
Shenzhen Mental Health Center, Shenzhen Kangning Hospital, Shenzhen Shi
PR China


Zeynep ÖZDEMİR
Department of Pharmaceutical Chemistry
İnönü University, Faculty of Pharmacy
Malatya
Turkey




RELATED BOOKS

.Frontiers in Clinical Drug Research-Dementia.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Natural Products in Clinical Trials.
.Good Quality Practice (GQP) in Pharmaceutical Manufacturing: A Handbook.
.Natural Products in Clinical Trials.
.Advances in Physicochemical Properties of Biopolymers: Part 1.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Cellular Mechanisms in Alzheimer’s Disease.